MHRA and police seize counterfeit weight-loss pens worth approximately £2 million

What Changed

The Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police seized counterfeit weight-loss medicines valued at approximately £2 million during a raid at an industrial unit in Birmingham. The operation on 14 October 2026 recovered more than 12,000 fake retatrutide and tirzepatide pens, together with packaging for around 30,000 additional products.

The announcement concerns enforcement against illegal medicines supply and a public-health warning, rather than a new regulatory measure.

Who Is Affected

The warning particularly concerns people buying weight-loss medicines from unregulated sources or considering GLP-1 treatment. The MHRA advises consulting a healthcare professional and obtaining medicines only from a registered pharmacy against a valid prescription.

People experiencing a suspected medicine side effect are encouraged to speak to their doctor, pharmacist or nurse and report it directly through the MHRA Yellow Card scheme.

Regulatory and Technical Implications

According to the MHRA, the seized products have not been assessed for safety, quality or effectiveness. Their contents cannot be guaranteed, and possible contamination with harmful substances has not been ruled out. This does not establish that a particular contaminant was detected.

The agency states that retatrutide is not authorised for use in the UK. Products sold as retatrutide outside legitimate clinical trials are being supplied illegally and could pose serious public-health risks. The release does not announce changes to medical-device legislation.

Manufacturer Actions

The announcement does not introduce manufacturer obligations, technical modifications or a compliance timetable. Its specific safety advice focuses on avoiding unregulated medicine sources, consulting healthcare professionals and reporting suspected side effects.

Confirmed Dates

The raid took place on 14 October 2026, and the press release was published on 15 October 2026. The source also describes earlier operations recovering around 12,000 doses in May 2026, around 2,000 doses in February 2026 and 5,000 unauthorised retatrutide and tirzepatide pens in October 2025. No new compliance deadline is specified.

Official Source

The source is the MHRA press release on GOV.UK, “Counterfeit weight loss pens worth £2 million seized by MHRA and West Midlands Police”. It also directs readers to the agency’s #FakeMeds website for advice on buying medicines safely online.

https://www.gov.uk/government/news/counterfeit-weight-loss-pens-worth-2-million-seized-by-mhra-and-west-mids-police